A Phase II Double-blind and Randomized Trial Comparing Concurrent Chemoradiotherapy Plus PG2 Injection Versus Concurrent Chemoradiotherapy Plus Placebo in Advanced Pharyngeal or Laryngeal Squamous Cell Carcinoma
Interventional
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Fatigue status by Brief Fatigue Inventory (BFI)
8 weeks
No
Hung-Ming HM Wang, MD
Principal Investigator
Chang Gung Memorial Hospital
Taiwan : Food and Drug Administration
PH-CP021
NCT01720563
December 2012
October 2014
Name | Location |
---|